Market Tracker

09/23 5:16pm ET

Peregrine Pharmaceuticals Inc (NASDAQ:PPHM)

0.4095
Delayed Data
As of Sep 23
 -0.0097 / -2.31%
Today’s Change
0.29
Today|||52-Week Range
1.33
-65.00%
Year-to-Date
No recent news for Peregrine Pharmaceuticals Inc.

Today’s Trading

Previous close0.42
Today’s open0.41
Day’s range0.40 - 0.42
Volume1,232,260
Average volume (3 months)1,386,256
Market cap$99.3M
Dividend yield--
Data as of 3:59pm ET, 09/23/2016

Growth & Valuation

Earnings growth (last year)+6.67%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+66.86%
P/E ratioNM
Price/Sales1.71
Price/Book1.94

Competitors

 Today’s
change
Today’s
% change
SBPHSpring Bank Pharmace...+1.05+9.01%
AFMDAffimed NV-0.06-2.00%
GEMPGemphire Therapeutic...-0.70-6.03%
ALIMAlimera Sciences Inc-0.01-0.61%
Data as of 3:59pm ET, 09/23/2016

Financials

Next reporting dateDecember 12, 2016
EPS forecast (this quarter)-$0.03
Annual revenue (last year)$44.7M
Annual profit (last year)-$55.7M
Net profit margin-124.54%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Steven W. King
CFO &
Principal Accounting Officer
Paul J. Lytle
Corporate headquarters
Tustin, California

Forecasts